This discrepancy in the statistical power of clinicopathological variables maybe caused by different inclusion criteria in other studies, analysis of bigger patients population with advanced and G4 tumours, too short follow-up or use of different levels for PSA BR (np. Here, KLK3 is linked to neoplasm.